KRAS and lung carcinoma: Focusing on lung cancer, in humans oncogenic KRAS mutations have been detected in premalignant lesions (Kanda et al., 2012) as well as in multiple regions within the same tumor (Zhang et al., 2014a), indicative of an early origin (Wistuba and Gazdar, 2006).